Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Free Report

White Paper_2017_State of China Life Science

State of China Life Science - 2017H1

Over $10B invested in last 18 months! 

China Clinical Trials 2017

Analysis of IND and NDA applications and approvals in China 2011-2017

Download free report on life science investment in China

Trials & Approvals

Updates on new clinical tirals being performed in China, trial updates and drug approvals...

BeiGene Starts China Trial of PARP Inhibitor in Ovarian Cancer Patients
Innovent Reports Positive Results for PD-1 Candidate; Files China NDA
CStone Pharma Starts Phase I Trial of PD-1 Molecule
Suzhou Alphamab to Start China Trial of Bispecific HER2 Inhibitor
MabSpace Starts US Trial of PD-L1 Drug; China Trial to Begin Soon
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Events
The 9th China Healthcare Investment Conference
Shanghai, China
March 27-29, 2018
Use chinabio18 for 20% discount